Le Lézard
Classified in: Health, Covid-19 virus
Subject: CFG

Commitment to universal pharmacare in Throne Speech worthy of standing ovation


Heart & Stroke applauds the government's commitment to quick action to making the plan a reality

OTTAWA, ON, Sept. 23, 2020 /CNW/ - Heart & Stroke welcomes the commitment to a national, universal pharmacare program in today's Speech from the Throne including a rare disease strategy and a national formulary. The government committed to working with provinces and territories willing to move forward without delay.

"We were pleased to see the commitment to implementing a universal pharmacare program in the Speech from the Throne. Access to medically necessary medication is an essential part of universal health coverage," says Doug Roth, CEO, Heart & Stroke. "A national plan will contain costs, reduce the burden on the health system and provide the access to medically necessary medication that everyone in Canada deserves."

Prior to COVID-19, 7.5 million people in Canada had no or inadequate prescription drug coverage. Between March and April of this year, three million jobs were lost due to the pandemic and unemployment remains high. This means even fewer Canadians have employment-related health benefits including prescription drug coverage. Also concerning is that pandemic-related unemployment has disproportionately impacted recent immigrants, racialized persons, and women. Women were already often in more precarious work situations including part-time positions that do not offer drug plans.

National, universal pharmacare is more important than ever to the health of Canadians.

"We look forward to working with the government on the health priorities outlined in the Throne Speech including expanded capacity for virtual care, and urge that other vital health policies be specified in the Health Minister's mandate letter including stronger regulations to protect youth from vaping, legislation to restrict food and beverage marketing to children and mandatory front-of-pack nutrition labelling," says Roth.

About Heart & Stroke
Life. We don't want you to miss it. That's why Heart & Stroke leads the fight against heart disease and stroke. We must generate the next medical breakthroughs, so Canadians don't miss out on precious moments. Together, we are working to prevent disease, save lives and promote recovery through research, health promotion and public policy.

SOURCE Heart and Stroke Foundation


These press releases may also interest you

at 20:31
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...



News published on and distributed by: